Particularly, as previously described, vaccination with ChAdOx1 nCov-19 may cause the rare development of immune thrombocytopenia mediated by platelet-activating antibodies against PF4, which clinically mimics heparin-induced autoimmune thrombocytopenia. The gene discussed is PF4; the disease is autoimmune thrombocytopenic purpura.